American Shared Hospital Services
AMEX:AMS
American Shared Hospital Services
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 8 full-time employees. The firm provides Gamma Knife stereotactic radiosurgery, a non-invasive procedure, which is an alternative to conventional brain surgery and/or radiation therapy. The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually is an out-patient procedure with lower risk of complications. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The firm provides Gamma Knife units to approximately 13 medical centers in 12 states in the United States and Gamma Knife units at stand-alone facilities in Lima, Peru, Guayaquil and Ecuador.
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 8 full-time employees. The firm provides Gamma Knife stereotactic radiosurgery, a non-invasive procedure, which is an alternative to conventional brain surgery and/or radiation therapy. The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually is an out-patient procedure with lower risk of complications. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The firm provides Gamma Knife units to approximately 13 medical centers in 12 states in the United States and Gamma Knife units at stand-alone facilities in Lima, Peru, Guayaquil and Ecuador.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
